LEMVIDA · SAN-ALE-2015-03
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A non-interventional observational study to evaluate changes in quality of life in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab (Lemtrada®) in routine clinical practice: LEMVIDA study
Sponsor: SANOFI GENZYME
Phase: IV
Area: Neuroimmunology